Publications by authors named "WJ Moore"

Claim this Profile
F
FAIR sharing of Chromatin Tracing datasets using the newly developed 4DN FISH Omics Format.
Rahi Navelkar, Andrea Cosolo, Bogdan Bintu, Yubao Cheng, Vincent Gardeux, William J Moore

ArXiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Efficacy of 1,2,4-Triazole-Based VCP/p97 Allosteric Inhibitors.
Neal Green, Matthew G LaPorte, William Paquette, Sipak Joyasawal, Pravat Mondal, William J Moore

J Med Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel and Reproducible Urinary Diagnostic Framework Reduces Health Care and Antibiotic Utilization for Urinary Tract Infections.
Kendall Kling, Teresa Zembower, W Justin Moore, Janna Williams, Amanda Vo

Open Forum Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase Inhibitors.
Lin Du, Brice A P Wilson, William J Moore, Masoumeh Dalilian, Shilpa R Shenoy

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
outbreak in a cardiothoracic transplant intensive care unit: implications for infection prevention practices and keeping pace with an evolving landscape.
Shardul N Rathod, Grace Barajas, Brooks I Mitchell, Michael Malczynski, W Justin Moore

Infect Control Hosp Epidemiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
Ryan K Shields, Lilian M Abbo, Renee Ackley, Samuel L Aitken, Benjamin Albrecht, W Justin Moore

Lancet Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of CHK-336, A First-in-Class, Liver-Targeted, Small-Molecule Lactate Dehydrogenase Inhibitor for Hyperoxaluria Treatment.
Jennifer H Cox, Marc-Olivier Boily, Alexandre Caron, Tao Sheng, Joyce Wu, William J Moore

J Am Soc Nephrol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort Study.
Kaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, Nikki Tran, Taryn A Eubank, W Justin Moore

Open Forum Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Antifungals and the Developing Pipeline.
Melissa D Johnson, W Justin Moore

Infect Dis Clin North Am· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement.
Zachary Nelson, Abdullah Tarik Aslan, Nathan P Beahm, Michelle Blyth, Matthew Cappiello, William Justin Moore

JAMA Netw Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent Activities in Mouse Models of Hematological and Solid Tumors.
James C Tarr, James M Salovich, Martin Aichinger, KyuOk Jeon, Nagarathanam Veerasamy, William J Moore

J Med Chem· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded profiling of WD repeat domain 5 inhibitors reveals actionable strategies for the treatment of hematologic malignancies.
Christian T Meyer, Brianna N Smith, Jing Wang, Kevin B Teuscher, Brian C Grieb, William J Moore

Proc Natl Acad Sci U S A· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new direction for cytomegalovirus prophylaxis among transplant recipients: Benefits and nonviral outcomes of letermovir use as primary CMV prophylaxis.
W Justin Moore, Catherine-Audrey Boutin, Sajal Tanna

Curr Opin Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors.
Kevin B Teuscher, Jonathan J Mills, Jianhua Tian, Changho Han, Kenneth M Meyers, William J Moore

J Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tecovirimat Use in Ambulatory and Hospitalized Patients With Monkeypox Virus Infection.
En-Ling Wu, Rebecca L Osborn, Christie M Bertram, W Justin Moore, Shannon R Galvin

Sex Transm Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Sara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, Musa Mubarez, Wesley D Kufel, W Justin Moore

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models.
Kevin B Teuscher, Somenath Chowdhury, Kenneth M Meyers, Jianhua Tian, Jiqing Sai, William J Moore

Proc Natl Acad Sci U S A· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort Study.
En-Ling Wu, Rebecca N Kumar, W Justin Moore, Gavin T Hall, Indre Vysniauskaite

J Gen Intern Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breakthrough daptomycin-, linezolid-, vancomycin-resistant bacteremia during protracted daptomycin therapy: A case report.
Nathan B Pincus, Tejas Joshi, Samuel W M Gatesy, Omar Al-Heeti, W Justin Moore

IDCases· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.
Kelli A Cole, Anna Y Zhou, Travis Jones, W Justin Moore, Elisabeth L Chandler

Clin Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization.
Kevin B Teuscher, Kenneth M Meyers, Qiangqiang Wei, Jonathan J Mills, Jianhua Tian, William J Moore

J Med Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A focus on the perceived value of preceptor support by pharmacy residents and fellows during the COVID-19 pandemic.
W Justin Moore, Andrew J Webb, Sheila K Wang

Am J Health Syst Pharm· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19.
Elizabeth Leung, Ryan L Crass, Sarah C J Jorgensen, Sumit Raybardhan, Bradley J Langford, W Justin Moore

Clin Pharmacokinet· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Lapadula et al.
Rebecca N Kumar, En-Ling Wu, Valentina Stosor, William J Moore, Chad Achenbach

Clin Infect Dis· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections.
Nicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger, William J Moore

Open Forum Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis